XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2022 $ 3,667 $ 135,461,361 $ (118,230,463) $ 17,234,565
Balance at the beginning (in shares) at Dec. 31, 2022 36,668,980      
Issuance of common stock in At the Market offering [1] $ 130 3,499,462   3,499,592
Issuance of common stock in At the Market offering (in shares) [1] 1,299,947      
Cashless exercise of stock options $ 2 (2)    
Cashless exercise of stock options (in shares) 19,530      
Stock-based compensation   819,064   819,064
Issuance of common stock related to vested restricted stock units (in shares) 3,289      
Net loss     (5,739,366) (5,739,366)
Balance at the end at Mar. 31, 2023 $ 3,799 139,779,885 (123,969,829) 15,813,855
Balance at the end (in shares) at Mar. 31, 2023 37,991,746      
Balance at the beginning at Dec. 31, 2023 $ 4,555 154,486,098 (145,491,559) $ 8,999,094
Balance at the beginning (in shares) at Dec. 31, 2023 45,553,026      
Issuance of common stock and warrants in registered direct offering (in shares)       1,833,323
Issuance of common stock in At the Market offering $ 183 3,194,364   $ 3,194,547
Issuance of common stock in At the Market offering (in shares) 1,833,323      
Stock-based compensation   546,232   546,232
Net loss     (10,922,101) (10,922,101)
Balance at the end at Mar. 31, 2024 $ 4,738 $ 158,226,694 $ (156,413,660) $ 1,817,772
Balance at the end (in shares) at Mar. 31, 2024 47,386,349      
[1] Includes gross proceeds of $3,607,827 less total issuance costs of $108,235